SAN FRANCISCO, Oct. 29 – Xanthon will partner with Duke University and University of North Carolina at Chapel Hill scientists in a two-year oligonucleotide array project that received funding from the North Carolina Biotechnology Center, the company announced Monday.

The project is called “Fabrication and Interrogation of Ultradense Oligonucleotide Arrays.” Xanthon will commercialize resulting technology, the company said.

Grant amount and details of the agreement between Xanthon and the universities were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.